SEARCH

SEARCH BY CITATION

References

  • Björkhem I. and Diczfalusy U. (2002) Oxysterols: friends, foes, or just fellow passengers? Arterioscler. Thromb. Vasc. Biol. 22, 734742.
  • Björkhem I. and Meaney S. (2004) Brain cholesterol: long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol. 24, 806815.
  • Björkhem I., Lϋtjohann D., Diczfalusy U., Stahle L., Ahlborg G. and Wahren J. (1998) Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 39, 15941600.
  • Borst P., Zelcer N. and Helvoort A. (2000) ABC transporters in lipid transport. Biochim. Biophys. Acta 1486, 128144.
  • Brown M. S. and Goldstein J. L. (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89, 331340.
  • Cao G., Bales K. R., DeMattos R. B. and Paul S. M. (2007) Liver X receptor-mediated gene regulation and cholesterol homeostasis in brain: relevance to Alzheimer’s disease therapeutics. Curr. Alzheimer Res. 4, 179184.
  • Cartagena C. M., Ahmed F., Burns M. P., Pajoohesh-Ganji A., Pak D. T., Faden A. I. and Rebeck G. W. (2008) Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain. J. Neurotrauma 25, 10871098.
  • Chang T. Y., Chang C. Y., Ohgami N. and Yamauchi Y. (2006) Cholesterol sensing, trafficking, and esterification. Annu. Rev. Cell Dev. Biol. 22, 129157.
  • DeBose-Boyd R. A. (2008) Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG-CoA reductase. Cell Res. 18, 609621.
  • Dietschy J. M. and Turley S. D. (2001) Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 12, 105112.
  • Farooqui A. A. and Horrocks L. A. (2007) Glycerophospholipids in Brain: Phospholipase A2 in neurological disorders. Springer, New York.
  • Farooqui A. A., Ong W. Y., Lu X. R., Halliwell B. and Horrocks L. A. (2001) Neurochemical consequences of kainate-induced toxicity in brain: involvement of arachidonic acid release and prevention of toxicity by phospholipase A2 inhibitors. Brain Res. Rev. 38, 6178.
  • Folch J., Lees M., Sloane G. and Stanley H. (1957) A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497509.
  • Han J. H., Kim Y. J., Han E. S. and Lee C. S. (2007) Prevention of 7-ketocholesterol-induced mitochondrial damage and cell death by calmodulin inhibition. Brain Res. 1137, 1119.
  • Hascalovici J. R., Vaya J., Khatib S., Holcroft C. A., Zukor H., Song W., Arvanitakis Z., Bennett D. A. and Schipper H. M. (2009) Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1. J. Neurochem. 110, 12411253.
  • He X., Jenner A. M., Ong W. Y., Farooqui A. A. and Patel S. C. (2006) Lovastatin modulates increased cholesterol and oxysterol levels and has a neuroprotective effect on rat hippocampal neurons after kainate injury. J. Neuropathol. Exp. Neurol. 65, 652663.
  • Kim J. H. and Ong W. Y. (2009) Localization of the transcription factor, sterol regulatory element binding protein-2 (SREBP-2) in the normal rat brain and changes after kainate-induced excitotoxic injury. J. Chem. Neuroanat. 37, 7177.
  • Kim Y. J., Han J. H., Han E. S. and Lee C. S. (2006) 7-Ketocholesterol enhances 1-methyl-4-phenylpyridinium-induced mitochondrial dysfunction and cell death in PC12 cells. J. Neural. Transm. 113, 18771885.
  • Kojima M., Masui T., Nemoto K. and Degawa M. (2004) Lead nitrate-induced development of hypercholesterolemia in rats: sterol-independent gene regulation of hepatic enzymes responsible for cholesterol homeostasis. Toxicol. Lett. 1, 3544.
  • Koldamova R. P., Lefterov I. M., Ikonomovic M. D., Skoko J., Lefterov P. I., Isanski B. A., DeKosky S. T. and Lazo J. S. (2003) 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. J. Biol. Chem. 278, 1324413256.
  • Kolsch H., Heun R., Kerksiek A., Bergmann K. V., Majer W. and Lutjohann D. (2004) Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients. Neurosci. Lett. 368, 303308.
  • Leoni V., Masterman T., Patel P., Meaney S., Diczfalusy V. and Björkhem I. (2003) Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers. J. Lipid Res. 44, 793799.
  • Leoni V., Lütjohann D. and Masterman T. (2005) Levels of 7-oxocholesterol in cerebrospinal fluid are more than one thousand times lower than reported in multiple sclerosis. J. Lipid Res. 46, 191195.
  • Livak K. J. and Schmittgen T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 225, 402408.
  • Lukiw W. J. (2006) Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer’s disease. Expert. Rev. Neurother. 6, 683693.
  • Lütjohann D., Brzezinka A., Barth E., Abramowski D., Staufenbiel M., Bergmann K., Beyreuther K., Multhaup G. and Bayer T. A. (2002) Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain. J. Lipid Res. 43, 10781085.
  • Michikawa M. (2004) Neurodegenerative disorders and cholesterol. Curr. Alzheimer Res. 1, 271275.
  • Ong W. Y., Goh E. W., Lu X. R., Farooqui A. A., Patel S. C. and Halliwell B. (2003) Increase in cholesterol and cholesterol oxidation products, and role of cholesterol oxidation products in kainate-induced neuronal injury. Brain Pathol. 13, 250262.
  • Repa J. J., Li H., Frank-Cannon T. C., Valasek M. A., Turley S. D., Tansey M. G. and Dietschy J. M. (2007) Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse. J. Neurosci. 6, 1447014480.
  • Russell D. W. (2000) Oxysterol biosynthetic enzymes. Biochim. Biophys. Acta 1529, 126135.
  • Sandhya T. L., Ong W. Y., Horrocks L. A. and Farooqui A. A. (1998) A light and electron microscopic study of cytoplasmic phospholipase A2 and cyclooxygenase-2 in the hippocampus after kainate lesions. Brain Res. 788, 223223.
  • Schippling S., Kontush A., Arlt S., Buhmann C., Stürenburg H. J., Mann U., Müller-Thomsen T. and Beisiegel U. (2000) Increased lipoprotein oxidation in Alzheimer’s disease. Free Radic. Biol. Med. 28, 351360.
  • Teunissen C. E., Floris S., Sonke M., Dijkstra C. D., De Vries H. E. and Lϋtjohann D. (2007) 24S-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis. J. Neurosci. Res. 85, 14991505.
  • Thelen K. M., Falkai P., Bayer T. A. and Lütjohann D. (2006) Cholesterol synthesis rate in human hippocampus declines with aging. Neurosci. Lett. 403, 1519.
  • Thwin M. M., Ong W. Y., Fong C. W., Sato K., Kodama K., Farooqui A. A. and Gopalakrishnakone P. (2000) Secretory phospholipase A2 activity in the normal and kainate injected rat brain, and inhibition by a peptide deived from python serum. Exp. Brain Res. 150, 427433.
  • Trasino S. E., Kim Y. S. and Wang T. T. (2009) Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells. Mol. Cancer Ther. 8, 19341945.
  • Trousson A., Bernard S., Petit P. X. et al. (2009) 25-hydroxycholesterol provokes oligodendrocyte cell line apoptosis and stimulates the secreted phospholipase A2 type IIA via LXR beta and PXR. J. Neurochem. 109, 945958.
  • Vaya J. and Schipper H. M. (2007) Oxysterols, cholesterol homeostasis, and Alzheimer disease. J. Neurochem. 102, 17271737.
  • Venkateswaran A., Laffitte B. A., Joseph S. B., Mak P. A., Wilpitz D. C., Edwards P. A. and Tontonoz P. (2000) Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRalpha. Proc. Natl. Acad. Sci. USA 97, 1209712102.
  • Wang Y., Muneton S., Sjövall J., Jovanovic J. N. and Griffiths W. J. (2008) The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron proteome. J. Proteome. Res. 7, 16061614.
  • Wόjcicka G., Jamroz-Wísniewska A., Horoszewicz K. and Beltowski J. (2007) Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism. Postepy Hig. Med. Dosw. 61, 736759.